Structure

Physi-Chem Properties

Molecular Weight:  406.21
Volume:  444.015
LogP:  6.961
LogD:  4.541
LogS:  -4.264
# Rotatable Bonds:  7
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.427
Synthetic Accessibility Score:  3.591
Fsp3:  0.346
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.761
MDCK Permeability:  1.5406774764414877e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.941
30% Bioavailability (F30%):  0.987

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.012
Plasma Protein Binding (PPB):  100.00860595703125%
Volume Distribution (VD):  1.938
Pgp-substrate:  1.1423171758651733%

ADMET: Metabolism

CYP1A2-inhibitor:  0.933
CYP1A2-substrate:  0.721
CYP2C19-inhibitor:  0.968
CYP2C19-substrate:  0.207
CYP2C9-inhibitor:  0.947
CYP2C9-substrate:  0.961
CYP2D6-inhibitor:  0.931
CYP2D6-substrate:  0.63
CYP3A4-inhibitor:  0.793
CYP3A4-substrate:  0.199

ADMET: Excretion

Clearance (CL):  7.951
Half-life (T1/2):  0.048

ADMET: Toxicity

hERG Blockers:  0.128
Human Hepatotoxicity (H-HT):  0.416
Drug-inuced Liver Injury (DILI):  0.443
AMES Toxicity:  0.058
Rat Oral Acute Toxicity:  0.11
Maximum Recommended Daily Dose:  0.898
Skin Sensitization:  0.399
Carcinogencity:  0.556
Eye Corrosion:  0.003
Eye Irritation:  0.196
Respiratory Toxicity:  0.856

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC265178

Natural Product ID:  NPC265178
Common Name*:   (1'r*,6'r*)-(2,6-Dihydroxy-4-Methoxyphenyl)-(3'-Isohexenyl-1'-Phenylcyclohex-3'-Enyl)Methanone
IUPAC Name:   (2,6-dihydroxy-4-methoxyphenyl)-[(1R,6R)-4-(4-methylpent-3-enyl)-6-phenylcyclohex-3-en-1-yl]methanone
Synonyms:   (+/-)-nicolaioidesin C
Standard InCHIKey:  VJYZXZFPGQYBKT-YADHBBJMSA-N
Standard InCHI:  InChI=1S/C26H30O4/c1-17(2)8-7-9-18-12-13-21(22(14-18)19-10-5-4-6-11-19)26(29)25-23(27)15-20(30-3)16-24(25)28/h4-6,8,10-12,15-16,21-22,27-28H,7,9,13-14H2,1-3H3/t21-,22+/m1/s1
SMILES:  CC(=CCCC1=CC[C@H]([C@@H](C1)c1ccccc1)C(=O)c1c(cc(cc1O)OC)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465443
PubChem CID:   11729201
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002650] Diarylheptanoids
        • [CHEMONTID:0002651] Linear diarylheptanoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8788 Renealmia nicolaioides Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[12444686]
NPO27600 Boesenbergia pandurata Species Zingiberaceae Eukaryota rhizomes Pindaya Township, Shan State, Myanmar 2004-NOV PMID[17896818]
NPO27600 Boesenbergia pandurata Species Zingiberaceae Eukaryota n.a. n.a. n.a. PMID[27508308]
NPO27600 Boesenbergia pandurata Species Zingiberaceae Eukaryota Rhizomes n.a. n.a. PMID[28099006]
NPO8788 Renealmia nicolaioides Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO27600 Boesenbergia pandurata Species Zingiberaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT440 Individual Protein Quinone oxidoreductase Mus musculus CD > 10.0 ug ml-1 PMID[478313]
NPT461 Cell Line PANC-1 Homo sapiens PC50 = 0.84 uM PMID[478314]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC265178 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9926 High Similarity NPC232021
0.9926 High Similarity NPC40118
0.9926 High Similarity NPC126534
0.9853 High Similarity NPC297600
0.9556 High Similarity NPC213603
0.9489 High Similarity NPC477956
0.9485 High Similarity NPC153979
0.9481 High Similarity NPC13575
0.9478 High Similarity NPC20560
0.9478 High Similarity NPC18877
0.9478 High Similarity NPC28753
0.9478 High Similarity NPC144051
0.9478 High Similarity NPC294593
0.9478 High Similarity NPC159623
0.9478 High Similarity NPC82225
0.9478 High Similarity NPC204960
0.9429 High Similarity NPC271288
0.942 High Similarity NPC172250
0.942 High Similarity NPC80962
0.942 High Similarity NPC326109
0.942 High Similarity NPC144118
0.942 High Similarity NPC219917
0.942 High Similarity NPC259166
0.942 High Similarity NPC48624
0.942 High Similarity NPC213659
0.942 High Similarity NPC11056
0.942 High Similarity NPC215311
0.942 High Similarity NPC204985
0.9416 High Similarity NPC251681
0.9416 High Similarity NPC21350
0.9416 High Similarity NPC472368
0.9416 High Similarity NPC243528
0.9412 High Similarity NPC186838
0.9412 High Similarity NPC24394
0.9412 High Similarity NPC66349
0.9412 High Similarity NPC1486
0.9412 High Similarity NPC168105
0.9412 High Similarity NPC249606
0.9412 High Similarity NPC41461
0.9412 High Similarity NPC25287
0.9412 High Similarity NPC274109
0.9412 High Similarity NPC477242
0.9412 High Similarity NPC150399
0.9412 High Similarity NPC477243
0.9412 High Similarity NPC98115
0.9412 High Similarity NPC477244
0.9412 High Similarity NPC12165
0.9407 High Similarity NPC103842
0.9407 High Similarity NPC286336
0.9362 High Similarity NPC25844
0.9362 High Similarity NPC477955
0.9353 High Similarity NPC26051
0.9353 High Similarity NPC469404
0.9353 High Similarity NPC55832
0.9353 High Similarity NPC268204
0.9353 High Similarity NPC52789
0.9353 High Similarity NPC282300
0.9348 High Similarity NPC295384
0.9348 High Similarity NPC283429
0.9348 High Similarity NPC472366
0.9348 High Similarity NPC109232
0.9343 High Similarity NPC116632
0.9343 High Similarity NPC303644
0.9343 High Similarity NPC294409
0.9343 High Similarity NPC209560
0.9343 High Similarity NPC7013
0.9343 High Similarity NPC162680
0.9343 High Similarity NPC317119
0.9343 High Similarity NPC181124
0.9343 High Similarity NPC472419
0.9338 High Similarity NPC156092
0.9338 High Similarity NPC131039
0.9333 High Similarity NPC56031
0.9333 High Similarity NPC192304
0.9333 High Similarity NPC139813
0.9333 High Similarity NPC337373
0.9333 High Similarity NPC188646
0.9333 High Similarity NPC175098
0.9333 High Similarity NPC472365
0.9333 High Similarity NPC263670
0.9333 High Similarity NPC242294
0.9333 High Similarity NPC312318
0.9328 High Similarity NPC475008
0.9328 High Similarity NPC186097
0.9328 High Similarity NPC475009
0.9301 High Similarity NPC329933
0.9296 High Similarity NPC308200
0.9296 High Similarity NPC475348
0.9296 High Similarity NPC261271
0.9291 High Similarity NPC311144
0.9291 High Similarity NPC476055
0.9286 High Similarity NPC202981
0.9281 High Similarity NPC159275
0.9281 High Similarity NPC241100
0.9281 High Similarity NPC253822
0.9281 High Similarity NPC284550
0.9281 High Similarity NPC101366
0.9281 High Similarity NPC129853
0.9281 High Similarity NPC76445
0.9275 High Similarity NPC55162
0.9275 High Similarity NPC279668
0.9275 High Similarity NPC90665
0.9275 High Similarity NPC12175
0.9275 High Similarity NPC278323
0.9275 High Similarity NPC309154
0.927 High Similarity NPC476333
0.927 High Similarity NPC472364
0.927 High Similarity NPC472367
0.927 High Similarity NPC473391
0.9259 High Similarity NPC205468
0.9259 High Similarity NPC87231
0.9259 High Similarity NPC257756
0.9259 High Similarity NPC212631
0.9259 High Similarity NPC129132
0.9231 High Similarity NPC152233
0.9231 High Similarity NPC39195
0.9231 High Similarity NPC145467
0.9225 High Similarity NPC299011
0.922 High Similarity NPC81697
0.922 High Similarity NPC18585
0.922 High Similarity NPC117836
0.922 High Similarity NPC166138
0.922 High Similarity NPC125894
0.922 High Similarity NPC113770
0.922 High Similarity NPC107177
0.922 High Similarity NPC223812
0.922 High Similarity NPC106985
0.922 High Similarity NPC85162
0.922 High Similarity NPC475705
0.922 High Similarity NPC77794
0.922 High Similarity NPC11700
0.922 High Similarity NPC51887
0.922 High Similarity NPC476178
0.922 High Similarity NPC278249
0.9214 High Similarity NPC321980
0.9214 High Similarity NPC470087
0.9214 High Similarity NPC26238
0.9214 High Similarity NPC470089
0.9214 High Similarity NPC110969
0.9214 High Similarity NPC49108
0.9209 High Similarity NPC55018
0.9209 High Similarity NPC18260
0.9209 High Similarity NPC220062
0.9209 High Similarity NPC301217
0.9209 High Similarity NPC303633
0.9209 High Similarity NPC53181
0.9209 High Similarity NPC96565
0.9209 High Similarity NPC217186
0.9209 High Similarity NPC316480
0.9209 High Similarity NPC470211
0.9209 High Similarity NPC216978
0.9209 High Similarity NPC78913
0.9203 High Similarity NPC322301
0.9203 High Similarity NPC23870
0.9203 High Similarity NPC255801
0.9197 High Similarity NPC234560
0.9197 High Similarity NPC39426
0.9191 High Similarity NPC27643
0.9185 High Similarity NPC64359
0.9185 High Similarity NPC189106
0.9185 High Similarity NPC112192
0.9185 High Similarity NPC262359
0.9185 High Similarity NPC128348
0.9185 High Similarity NPC309717
0.9185 High Similarity NPC164236
0.9185 High Similarity NPC27490
0.9185 High Similarity NPC175738
0.9185 High Similarity NPC308037
0.9185 High Similarity NPC313618
0.9185 High Similarity NPC66384
0.9167 High Similarity NPC473016
0.9167 High Similarity NPC471114
0.9161 High Similarity NPC34802
0.9161 High Similarity NPC10990
0.9161 High Similarity NPC300988
0.9155 High Similarity NPC131568
0.9155 High Similarity NPC216538
0.9155 High Similarity NPC303185
0.9155 High Similarity NPC131579
0.9155 High Similarity NPC473013
0.9155 High Similarity NPC311741
0.9155 High Similarity NPC184649
0.9155 High Similarity NPC326500
0.9155 High Similarity NPC473015
0.9155 High Similarity NPC328623
0.9155 High Similarity NPC235217
0.9155 High Similarity NPC473014
0.9155 High Similarity NPC273538
0.9155 High Similarity NPC234629
0.9149 High Similarity NPC32739
0.9149 High Similarity NPC265040
0.9149 High Similarity NPC10937
0.9149 High Similarity NPC324436
0.9149 High Similarity NPC76372
0.9149 High Similarity NPC223500
0.9149 High Similarity NPC220998
0.9149 High Similarity NPC296917
0.9149 High Similarity NPC64915
0.9149 High Similarity NPC66515
0.9149 High Similarity NPC182852

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC265178 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9197 High Similarity NPD1510 Phase 2
0.9191 High Similarity NPD1607 Approved
0.9185 High Similarity NPD1240 Approved
0.9155 High Similarity NPD4378 Clinical (unspecified phase)
0.8929 High Similarity NPD1550 Clinical (unspecified phase)
0.8929 High Similarity NPD1552 Clinical (unspecified phase)
0.8865 High Similarity NPD1549 Phase 2
0.8859 High Similarity NPD8443 Clinical (unspecified phase)
0.8759 High Similarity NPD7410 Clinical (unspecified phase)
0.8723 High Similarity NPD2796 Approved
0.8716 High Similarity NPD4380 Phase 2
0.8667 High Similarity NPD2393 Clinical (unspecified phase)
0.8643 High Similarity NPD6651 Approved
0.8601 High Similarity NPD970 Clinical (unspecified phase)
0.8543 High Similarity NPD7819 Suspended
0.8533 High Similarity NPD7411 Suspended
0.8497 Intermediate Similarity NPD7075 Discontinued
0.8483 Intermediate Similarity NPD3750 Approved
0.8477 Intermediate Similarity NPD1934 Approved
0.8471 Intermediate Similarity NPD7473 Discontinued
0.8435 Intermediate Similarity NPD1511 Approved
0.8421 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD2801 Approved
0.8414 Intermediate Similarity NPD2800 Approved
0.8397 Intermediate Similarity NPD6232 Discontinued
0.8344 Intermediate Similarity NPD6599 Discontinued
0.8333 Intermediate Similarity NPD2935 Discontinued
0.8333 Intermediate Similarity NPD6959 Discontinued
0.8322 Intermediate Similarity NPD1512 Approved
0.8312 Intermediate Similarity NPD7768 Phase 2
0.8311 Intermediate Similarity NPD6799 Approved
0.8291 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8264 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8258 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8255 Intermediate Similarity NPD2533 Approved
0.8255 Intermediate Similarity NPD2534 Approved
0.8255 Intermediate Similarity NPD2532 Approved
0.8235 Intermediate Similarity NPD6801 Discontinued
0.8207 Intermediate Similarity NPD1551 Phase 2
0.8201 Intermediate Similarity NPD2798 Approved
0.8194 Intermediate Similarity NPD3882 Suspended
0.8163 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD3749 Approved
0.8138 Intermediate Similarity NPD2799 Discontinued
0.8138 Intermediate Similarity NPD3748 Approved
0.8108 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8099 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8082 Intermediate Similarity NPD6100 Approved
0.8082 Intermediate Similarity NPD6099 Approved
0.8067 Intermediate Similarity NPD7390 Discontinued
0.8063 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6166 Phase 2
0.8063 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.8038 Intermediate Similarity NPD5494 Approved
0.8027 Intermediate Similarity NPD2344 Approved
0.8025 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD3817 Phase 2
0.7987 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7986 Intermediate Similarity NPD943 Approved
0.7972 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7958 Intermediate Similarity NPD4908 Phase 1
0.7919 Intermediate Similarity NPD1243 Approved
0.7914 Intermediate Similarity NPD3972 Approved
0.7867 Intermediate Similarity NPD4628 Phase 3
0.7866 Intermediate Similarity NPD7074 Phase 3
0.7853 Intermediate Similarity NPD3818 Discontinued
0.7847 Intermediate Similarity NPD3268 Approved
0.7842 Intermediate Similarity NPD1610 Phase 2
0.7842 Intermediate Similarity NPD1201 Approved
0.7818 Intermediate Similarity NPD5953 Discontinued
0.7815 Intermediate Similarity NPD2309 Approved
0.7806 Intermediate Similarity NPD3226 Approved
0.7806 Intermediate Similarity NPD7458 Discontinued
0.7805 Intermediate Similarity NPD7054 Approved
0.78 Intermediate Similarity NPD2654 Approved
0.7792 Intermediate Similarity NPD5403 Approved
0.7792 Intermediate Similarity NPD920 Approved
0.7771 Intermediate Similarity NPD6559 Discontinued
0.7763 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7472 Approved
0.7748 Intermediate Similarity NPD7003 Approved
0.7746 Intermediate Similarity NPD2797 Approved
0.7746 Intermediate Similarity NPD1470 Approved
0.7746 Intermediate Similarity NPD1203 Approved
0.7736 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7724 Intermediate Similarity NPD2313 Discontinued
0.7711 Intermediate Similarity NPD6797 Phase 2
0.7697 Intermediate Similarity NPD5844 Phase 1
0.7697 Intermediate Similarity NPD7286 Phase 2
0.7677 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7667 Intermediate Similarity NPD2346 Discontinued
0.7665 Intermediate Similarity NPD7251 Discontinued
0.7662 Intermediate Similarity NPD5401 Approved
0.7662 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7619 Intermediate Similarity NPD7808 Phase 3
0.7607 Intermediate Similarity NPD5710 Approved
0.7607 Intermediate Similarity NPD5711 Approved
0.7606 Intermediate Similarity NPD4749 Approved
0.76 Intermediate Similarity NPD5404 Approved
0.76 Intermediate Similarity NPD5408 Approved
0.76 Intermediate Similarity NPD5406 Approved
0.76 Intermediate Similarity NPD5405 Approved
0.7589 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD4360 Phase 2
0.7586 Intermediate Similarity NPD6832 Phase 2
0.7586 Intermediate Similarity NPD4363 Phase 3
0.7562 Intermediate Similarity NPD5402 Approved
0.7561 Intermediate Similarity NPD3926 Phase 2
0.7554 Intermediate Similarity NPD1548 Phase 1
0.7552 Intermediate Similarity NPD1876 Approved
0.7548 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD4361 Phase 2
0.7543 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7536 Intermediate Similarity NPD9493 Approved
0.7535 Intermediate Similarity NPD9717 Approved
0.7535 Intermediate Similarity NPD1608 Approved
0.7534 Intermediate Similarity NPD4625 Phase 3
0.7533 Intermediate Similarity NPD4308 Phase 3
0.7533 Intermediate Similarity NPD7033 Discontinued
0.7515 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1164 Approved
0.75 Intermediate Similarity NPD3267 Approved
0.75 Intermediate Similarity NPD3266 Approved
0.7483 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7483 Intermediate Similarity NPD3764 Approved
0.7465 Intermediate Similarity NPD422 Phase 1
0.7453 Intermediate Similarity NPD4288 Approved
0.7448 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD37 Approved
0.7431 Intermediate Similarity NPD1283 Approved
0.7429 Intermediate Similarity NPD9545 Approved
0.7423 Intermediate Similarity NPD919 Approved
0.7417 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD1465 Phase 2
0.7376 Intermediate Similarity NPD1651 Approved
0.7375 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD1247 Approved
0.7333 Intermediate Similarity NPD230 Phase 1
0.7333 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD5124 Phase 1
0.7324 Intermediate Similarity NPD17 Approved
0.732 Intermediate Similarity NPD1471 Phase 3
0.7317 Intermediate Similarity NPD6234 Discontinued
0.731 Intermediate Similarity NPD3225 Approved
0.7305 Intermediate Similarity NPD2403 Approved
0.7301 Intermediate Similarity NPD4967 Phase 2
0.7301 Intermediate Similarity NPD4965 Approved
0.7301 Intermediate Similarity NPD4966 Approved
0.7297 Intermediate Similarity NPD3027 Phase 3
0.7294 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7289 Intermediate Similarity NPD7229 Phase 3
0.7267 Intermediate Similarity NPD4307 Phase 2
0.7257 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7248 Intermediate Similarity NPD411 Approved
0.7241 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD8434 Phase 2
0.7239 Intermediate Similarity NPD2296 Approved
0.7235 Intermediate Similarity NPD1729 Discontinued
0.723 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD7199 Phase 2
0.7222 Intermediate Similarity NPD1281 Approved
0.7219 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD6355 Discontinued
0.7219 Intermediate Similarity NPD1933 Approved
0.7215 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7207 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD2932 Approved
0.7203 Intermediate Similarity NPD4626 Approved
0.7197 Intermediate Similarity NPD3300 Phase 2
0.7194 Intermediate Similarity NPD1241 Discontinued
0.7182 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD5760 Phase 2
0.7178 Intermediate Similarity NPD5761 Phase 2
0.717 Intermediate Similarity NPD6273 Approved
0.7168 Intermediate Similarity NPD8312 Approved
0.7168 Intermediate Similarity NPD8313 Approved
0.7163 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD2861 Phase 2
0.7162 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7159 Intermediate Similarity NPD4287 Approved
0.7153 Intermediate Similarity NPD4750 Phase 3
0.7152 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD1613 Approved
0.7143 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8150 Discontinued
0.7133 Intermediate Similarity NPD6798 Discontinued
0.7133 Intermediate Similarity NPD1296 Phase 2
0.7123 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3751 Discontinued
0.7105 Intermediate Similarity NPD447 Suspended
0.7088 Intermediate Similarity NPD6780 Approved
0.7088 Intermediate Similarity NPD6776 Approved
0.7088 Intermediate Similarity NPD6781 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data